Patients who rely on recombinant, protein-based drugs must often endure frequent injections, often several times a week, or intravenous therapy. Researchers at Children's Hospital Boston demonstrate the possibility that blood ...
Nov 15, 2011
0
0
Treating chronic hepatitis C infection with antiviral drugs could halve the risk of developing the most common form of liver cancer, in some cases, indicates an analysis of the published research in one of the new BMJ Open ...
Oct 22, 2012
0
0
A powerful antiviral protein may act as a checkpoint for keeping or ending a pregnancy.
Jan 5, 2018
0
59
New data from a number of clinical trials presented for the first time at the International Liver Congress 2012 provides hope for previously difficult to treat hepatitis C (HCV) patient populations.
Apr 19, 2012
0
0
Scientists have determined that La Crosse virus (LACV), which can cause inflammation of the brain, or encephalitis, in children, affects brain cells differently depending on their developmental stage. Neurons—the primary ...
Nov 26, 2019
0
5
Of the more than 700,000 Americans who suffer a heart attack each year, about a quarter go on to develop heart failure. Scientists don't fully understand how one condition leads to the other, but researchers in the Perelman ...
Feb 6, 2017
0
4
Researchers at Karolinska Institutet in Sweden have published new findings in the journal Cancer Discovery showing how pharmacological activation of the protein p53 boosts the immune response against tumours. The results ...
Jul 6, 2021
0
7
The body's defense strategies against viral infections are as diverse as the attacks themselves. A team from the Technical University of Munich (TUM) and the Max Planck Institute for Biochemistry has conducted a systematic ...
Mar 4, 2019
0
51
New research announced at the International Liver Congress 2014 today provides new hope for the notoriously difficult-to-treat population of liver transplant patients with recurring hepatitis C (HCV).
Apr 11, 2014
0
0
Omega-3 fatty acid supplements were not associated with beneficial effects on disease activity in patients with relapsing-remitting multiple sclerosis, according to a report of a randomized controlled trial published Online ...
Apr 23, 2012
0
0
